The perspectives of street-involved youth who use drugs regarding the acceptability and feasibility of HIV pre-exposure prophylaxis: a qualitative study.
HIV prevention
Vulnerable youth
pre-exposure prophylaxis
qualitative
Journal
AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
pmc-release:
01
04
2024
medline:
21
4
2023
pubmed:
15
6
2022
entrez:
14
6
2022
Statut:
ppublish
Résumé
Street-involved youth who use drugs (YWUD) face an elevated risk of HIV acquisition and represent a key population for HIV prevention initiatives, including pre-exposure prophylaxis (PrEP). However, little is known regarding the acceptability and feasibility of PrEP uptake and adherence among this multiply-marginalized population. Semi-structured qualitative interviews were conducted with 24 street-involved YWUD (ages 17-24) to examine their perspectives toward PrEP; youth were recruited through a longitudinal prospective cohort study in Vancouver, Canada. Youth reported high levels of ambivalence toward PrEP despite engagement in HIV-related risk behaviors. This ambivalence was driven by misperceptions regarding HIV transmission, including stigmatizing associations between HIV transmission and personal hygiene. Such misperceptions led participants to enact strategies that were ineffective in preventing HIV transmission. Participants contested their inclusion as a "key population" for PrEP, which limited their enthusiasm for PrEP uptake and adherence. Participants also highlighted that wider social-structural inequities (e.g., housing vulnerability, poverty) that produced HIV-related risks were likely to undermine sustained PrEP use. Findings demonstrate the need for tailored implementation strategies to increase PrEP acceptability, including targeted education and anti-stigma interventions to increase awareness about HIV transmission. Interventions should also target structural inequities in order to fully address HIV risk and PrEP ambivalence.
Identifiants
pubmed: 35698454
doi: 10.1080/09540121.2022.2085868
pmc: PMC9930182
mid: NIHMS1814020
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
480-487Subventions
Organisme : NIDA NIH HHS
ID : R01 DA043408
Pays : United States
Références
Int J Drug Policy. 2015 Feb;26 Suppl 1:S12-5
pubmed: 25727258
Soc Sci Med. 2005 Sep;61(5):1026-44
pubmed: 15955404
Soc Sci Med. 2017 Apr;178:87-94
pubmed: 28214449
Int J Drug Policy. 2014 Mar;25(2):291-6
pubmed: 24405564
AIDS Patient Care STDS. 2018 Dec;32(12):529-537
pubmed: 30311777
AIDS Behav. 2015 May;19(5):752-7
pubmed: 25086669
AIDS Behav. 2017 Feb;21(2):402-409
pubmed: 27351192
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
Cult Health Sex. 2008 Nov;10(8):787-99
pubmed: 18975227
Health Serv Res. 2007 Aug;42(4):1758-72
pubmed: 17286625
Drug Alcohol Depend. 2019 Feb 1;195:148-155
pubmed: 30639794
BMC Public Health. 2009 Jan 09;9:7
pubmed: 19134203
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
AIDS Behav. 2015 Oct;19(10):1792-800
pubmed: 25845530
J Health Care Poor Underserved. 2005 May;16(2):345-61
pubmed: 15937397
Drug Alcohol Depend. 2010 Aug 1;110(3):254-8
pubmed: 20456875
Soc Sci Med. 2019 Aug;234:112384
pubmed: 31254965
AIDS Behav. 2018 Nov;22(11):3550-3565
pubmed: 29344740
AIDS. 2007 Sep 12;21(14):1923-32
pubmed: 17721100
Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35
pubmed: 23490450
Harm Reduct J. 2018 Nov 12;15(1):55
pubmed: 30419926
Soc Sci Med. 2014 Mar;105:59-66
pubmed: 24508718
CMAJ. 2017 Nov 27;189(47):E1448-E1458
pubmed: 29180384
AIDS Behav. 2005 Sep;9(3):251-65
pubmed: 16088369
Curr Opin HIV AIDS. 2013 Jan;8(1):41-9
pubmed: 23188178
AIDS Behav. 2016 Feb;20(2):377-84
pubmed: 26040989
Lancet Infect Dis. 2014 Sep;14(9):820-9
pubmed: 25065857
J Acquir Immune Defic Syndr. 2010 Jul;54 Suppl 1:S5-6
pubmed: 20571423
AIDS Care. 2019 Jan;31(1):69-76
pubmed: 29999421
PLoS Med. 2014 Mar 04;11(3):e1001613
pubmed: 24595035
Health Place. 2009 Sep;15(3):753-60
pubmed: 19201642
Cult Health Sex. 2012;14(2):139-50
pubmed: 22084992
JAMA Intern Med. 2016 Jan;176(1):75-84
pubmed: 26571482
Lancet. 2010 Jul 24;376(9737):268-84
pubmed: 20650523
AIDS Behav. 2014 Sep;18(9):1694-700
pubmed: 24752703
AIDS Behav. 2017 Sep;21(9):2717-2725
pubmed: 28409267